heart failure Archives - Journal for Clinical Studies

Current Edition

Regional News

Eli Lilly and Boehringer Ingelheim’s Jardiance stays on its heart failure winning streak⁠—this time in acute patients

Three months after earning an approval to treat chronic heart failure with their SGLT2 inhibitor Jardiance, Eli Lilly and Boehringer Ingelheim have posted new data th...

17 November 2021 Regional News acute heart failure | Boehringer Ingelheim

Continue Reading →

Regional News

J&J’s Invokana chases AZ’s Farxiga and Lilly’s Jardiance with phase 3 heart failure win

Chasing rivals from AstraZeneca and Eli Lilly/Boehringer Ingelheim, Johnson & Johnson's Invokana is vying for a piece of the lucrative heart failure market. J&am...

17 November 2021 Regional News AstraZeneca | Eli Lilly

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

Eli Lilly and Boehringer Ingelheim’s Jardiance stays on its heart failure winning streak⁠—this time in acute patients

J&J’s Invokana chases AZ’s Farxiga and Lilly’s Jardiance with phase 3 heart failure win

Journal for Clinical Studies